Click for best price
Cancer Therapeutics And Biotherapeutics Market Size, Share 2022
The global cancer therapeutics and biotherapeutics market is drived by the introduction of products such as gemcitabin, oxaliplatin and pemetrexed.
This report contains market size and forecasts of Cancer Therapeutics And Biotherapeutics in Global, including the following market information:
The global Cancer Therapeutics And Biotherapeutics market was valued at 8959.4 million in 2021 and is projected to reach US$ 11930 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Therapeutics And Biotherapeutics include Bristol-Myers Squibb, AstraZeneca, Pfizer, Biogen IDEC, Sanofi, Genentech, Novartis, Johnson & Johnson and Roche and Schering-Plough. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Therapeutics And Biotherapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Therapeutics And Biotherapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Therapeutics And Biotherapeutics Market Segment Percentages, by Type, 2021 (%)
- Chemotherapy
- Radiation Therapy
- Hormone Therapy
- Biotherapy
Global Cancer Therapeutics And Biotherapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Therapeutics And Biotherapeutics Market Segment Percentages, by Application, 2021 (%)
- Consumption
- Household
- Hospital
Global Cancer Therapeutics And Biotherapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Therapeutics And Biotherapeutics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cancer Therapeutics And Biotherapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Cancer Therapeutics And Biotherapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol-Myers Squibb
- AstraZeneca
- Pfizer
- Biogen IDEC
- Sanofi
- Genentech
- Novartis
- Johnson & Johnson
- Roche and Schering-Plough
| Report Attributes |
Report Details |
| Report Title |
Cancer Therapeutics And Biotherapeutics Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Therapeutics And Biotherapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Therapeutics And Biotherapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Therapeutics And Biotherapeutics Overall Market Size
2.1 Global Cancer Therapeutics And Biotherapeutics Market Size: 2021 VS 2028
2.2 Global Cancer Therapeutics And Biotherapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Therapeutics And Biotherapeutics Players in Global Market
3.2 Top Global Cancer Therapeutics And Biotherapeutics Companies Ranked by Revenue
3.3 Global Cancer Therapeutics And Biotherapeutics Revenue by Companies
3.4 Top 3 and Top 5 Cancer Therapeutics And Biotherapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Therapeutics And Biotherapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Therapeutics And Biotherapeutics Players in Global Market
3.6.1 List of Global Tier 1 Cancer Therapeutics And Biotherapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Therapeutics And Biotherapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer Therapeutics And Biotherapeutics Market Size Markets, 2021 & 2028
4.1.2 Chemotherapy
4.1.3 Radiation Therapy
4.1.4 Hormone Therapy
4.1.5 Biotherapy
4.2 By Type - Global Cancer Therapeutics And Biotherapeutics Revenue & Forecasts
4.2.1 By Type - Global Cancer Therapeutics And Biotherapeutics Revenue, 2017-2022
4.2.2 By Type - Global Cancer Therapeutics And Biotherapeutics Revenue, 2023-2028
4.2.3 By Type - Global Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Therapeutics And Biotherapeutics Market Size, 2021 & 2028
5.1.2 Consumption
5.1.3 Household
5.1.4 Hospital
5.2 By Application - Global Cancer Therapeutics And Biotherapeutics Revenue & Forecasts
5.2.1 By Application - Global Cancer Therapeutics And Biotherapeutics Revenue, 2017-2022
5.2.2 By Application - Global Cancer Therapeutics And Biotherapeutics Revenue, 2023-2028
5.2.3 By Application - Global Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Therapeutics And Biotherapeutics Market Size, 2021 & 2028
6.2 By Region - Global Cancer Therapeutics And Biotherapeutics Revenue & Forecasts
6.2.1 By Region - Global Cancer Therapeutics And Biotherapeutics Revenue, 2017-2022
6.2.2 By Region - Global Cancer Therapeutics And Biotherapeutics Revenue, 2023-2028
6.2.3 By Region - Global Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer Therapeutics And Biotherapeutics Revenue, 2017-2028
6.3.2 US Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.3.3 Canada Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.3.4 Mexico Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer Therapeutics And Biotherapeutics Revenue, 2017-2028
6.4.2 Germany Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.4.3 France Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.4.4 U.K. Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.4.5 Italy Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.4.6 Russia Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.4.8 Benelux Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer Therapeutics And Biotherapeutics Revenue, 2017-2028
6.5.2 China Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.5.3 Japan Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.5.4 South Korea Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.5.6 India Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer Therapeutics And Biotherapeutics Revenue, 2017-2028
6.6.2 Brazil Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.6.3 Argentina Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Therapeutics And Biotherapeutics Revenue, 2017-2028
6.7.2 Turkey Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.7.3 Israel Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
6.7.5 UAE Cancer Therapeutics And Biotherapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Corporate Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Major Product Offerings
7.1.4 Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Revenue in Global Market (2017-2022)
7.1.5 Bristol-Myers Squibb Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Cancer Therapeutics And Biotherapeutics Major Product Offerings
7.2.4 AstraZeneca Cancer Therapeutics And Biotherapeutics Revenue in Global Market (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Cancer Therapeutics And Biotherapeutics Major Product Offerings
7.3.4 Pfizer Cancer Therapeutics And Biotherapeutics Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Biogen IDEC
7.4.1 Biogen IDEC Corporate Summary
7.4.2 Biogen IDEC Business Overview
7.4.3 Biogen IDEC Cancer Therapeutics And Biotherapeutics Major Product Offerings
7.4.4 Biogen IDEC Cancer Therapeutics And Biotherapeutics Revenue in Global Market (2017-2022)
7.4.5 Biogen IDEC Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Cancer Therapeutics And Biotherapeutics Major Product Offerings
7.5.4 Sanofi Cancer Therapeutics And Biotherapeutics Revenue in Global Market (2017-2022)
7.5.5 Sanofi Key News
7.6 Genentech
7.6.1 Genentech Corporate Summary
7.6.2 Genentech Business Overview
7.6.3 Genentech Cancer Therapeutics And Biotherapeutics Major Product Offerings
7.6.4 Genentech Cancer Therapeutics And Biotherapeutics Revenue in Global Market (2017-2022)
7.6.5 Genentech Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Cancer Therapeutics And Biotherapeutics Major Product Offerings
7.7.4 Novartis Cancer Therapeutics And Biotherapeutics Revenue in Global Market (2017-2022)
7.7.5 Novartis Key News
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Corporate Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Cancer Therapeutics And Biotherapeutics Major Product Offerings
7.8.4 Johnson & Johnson Cancer Therapeutics And Biotherapeutics Revenue in Global Market (2017-2022)
7.8.5 Johnson & Johnson Key News
7.9 Roche and Schering-Plough
7.9.1 Roche and Schering-Plough Corporate Summary
7.9.2 Roche and Schering-Plough Business Overview
7.9.3 Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Major Product Offerings
7.9.4 Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Revenue in Global Market (2017-2022)
7.9.5 Roche and Schering-Plough Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Therapeutics And Biotherapeutics Market Opportunities & Trends in Global Market
Table 2. Cancer Therapeutics And Biotherapeutics Market Drivers in Global Market
Table 3. Cancer Therapeutics And Biotherapeutics Market Restraints in Global Market
Table 4. Key Players of Cancer Therapeutics And Biotherapeutics in Global Market
Table 5. Top Cancer Therapeutics And Biotherapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Therapeutics And Biotherapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Therapeutics And Biotherapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Therapeutics And Biotherapeutics Product Type
Table 9. List of Global Tier 1 Cancer Therapeutics And Biotherapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Therapeutics And Biotherapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Therapeutics And Biotherapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Therapeutics And Biotherapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Therapeutics And Biotherapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Therapeutics And Biotherapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bristol-Myers Squibb Corporate Summary
Table 31. Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Product Offerings
Table 32. Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Cancer Therapeutics And Biotherapeutics Product Offerings
Table 35. AstraZeneca Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Cancer Therapeutics And Biotherapeutics Product Offerings
Table 38. Pfizer Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Biogen IDEC Corporate Summary
Table 40. Biogen IDEC Cancer Therapeutics And Biotherapeutics Product Offerings
Table 41. Biogen IDEC Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Cancer Therapeutics And Biotherapeutics Product Offerings
Table 44. Sanofi Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Genentech Corporate Summary
Table 46. Genentech Cancer Therapeutics And Biotherapeutics Product Offerings
Table 47. Genentech Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Cancer Therapeutics And Biotherapeutics Product Offerings
Table 50. Novartis Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Johnson & Johnson Corporate Summary
Table 52. Johnson & Johnson Cancer Therapeutics And Biotherapeutics Product Offerings
Table 53. Johnson & Johnson Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Roche and Schering-Plough Corporate Summary
Table 55. Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Product Offerings
Table 56. Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cancer Therapeutics And Biotherapeutics Segment by Type in 2021
Figure 2. Cancer Therapeutics And Biotherapeutics Segment by Application in 2021
Figure 3. Global Cancer Therapeutics And Biotherapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Therapeutics And Biotherapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Therapeutics And Biotherapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Therapeutics And Biotherapeutics Revenue in 2021
Figure 8. By Type - Global Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
Figure 12. US Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
Figure 24. China Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Therapeutics And Biotherapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Therapeutics And Biotherapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bristol-Myers Squibb Cancer Therapeutics And Biotherapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Cancer Therapeutics And Biotherapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Cancer Therapeutics And Biotherapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biogen IDEC Cancer Therapeutics And Biotherapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Cancer Therapeutics And Biotherapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Genentech Cancer Therapeutics And Biotherapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Cancer Therapeutics And Biotherapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson & Johnson Cancer Therapeutics And Biotherapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche and Schering-Plough Cancer Therapeutics And Biotherapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
